Stephen Oxley Buys 5 Shares of Croda International (LON:CRDA) Stock

Croda International Plc (LON:CRDAGet Free Report) insider Stephen Oxley purchased 5 shares of the company’s stock in a transaction dated Wednesday, June 10th. The stock was purchased at an average price of GBX 2,965 per share, with a total value of £148.25.

Croda International Price Performance

Shares of LON:CRDA traded down GBX 16 on Monday, hitting GBX 3,036. The company had a trading volume of 19,294,742 shares, compared to its average volume of 4,394,893. The business has a 50 day moving average of GBX 2,918.62 and a 200 day moving average of GBX 2,840.60. Croda International Plc has a 52-week low of GBX 2,426.77 and a 52-week high of GBX 3,312. The company has a market cap of £4.23 billion, a PE ratio of 68.38, a PEG ratio of 1.40 and a beta of 0.91. The company has a current ratio of 1.99, a quick ratio of 2.25 and a debt-to-equity ratio of 31.85.

Analysts Set New Price Targets

Several brokerages recently weighed in on CRDA. Deutsche Bank Aktiengesellschaft cut their target price on shares of Croda International from GBX 3,100 to GBX 3,000 and set a “hold” rating for the company in a research note on Tuesday, March 24th. Jefferies Financial Group restated a “hold” rating and issued a GBX 3,000 price target on shares of Croda International in a report on Wednesday, April 22nd. Finally, Morgan Stanley upgraded Croda International to an “overweight” rating and lifted their price target for the company from GBX 3,280 to GBX 3,350 in a report on Wednesday, March 25th. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of GBX 3,140.

Read Our Latest Stock Report on CRDA

Croda International Company Profile

(Get Free Report)

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

Further Reading

Insider Buying and Selling by Quarter for Croda International (LON:CRDA)

Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.